RWE & Post-Approval Studies
Maximizing the impact of your product
From early on in clinical development, we help define strategies and solutions to generate and communicate evidence that demonstrates product value for stakeholders. We've established a 30+ year track record of helping sponsors optimize clinical and commercial value.
Proven expertise
Over 30 years of experience in real world evidence (RWE) and post-approval studies.
Global experience
Conducted studies in ~60 countries with a team of over 1,000 RWE experts.
Comprehensive services
From real-world data generation to patient registries and safety surveillance.
Plan your asset’s path to success—from the start
We've been performing RWE and Phase IIIB/IV studies for more than 30 years, helping sponsors efficiently generate the data needed to maximize the value of their assets. We help you proactively plan your asset's path to success from the start by combining our unique perspectives and precision delivery. Our medical affairs and post-marketing teams partner with you to deliver customized solutions that meet your design, peri- and post-approval needs.
Enhancing the benefits of your compound throughout its life cycle
You have needs-we have solutions. Whether you need to explore the design elements of a future clinical program, fulfill a regulatory commitment, anticipate a business opportunity or react to a market event, we are agile enough to respond to your challenges. Fortrea's portfolio of services provides you with the strategies and solutions you need including:
- RWE策略、前瞻性观察研究和回顾性数据分析
- IIIb期/IV期临床试验
- 筛查和自然历史研究
- 授权后安全性和有效性研究
- 低干预临床试验
- 观察研究
- 疾病/药物名册
- 生活质量和患者报告结果
- Health outcomes and RWD for healthcare decision-making
- 健康经济学评估和医疗技术评估意见书
- 文献综述、因果分析和元分析